A multicenter cohort study of treatments and hospital outcomes in neonatal abstinence syndrome

Pediatrics

Volumn 134, Issue 2, 2014, Pages

  Hall, Eric S ^a   Wexelblatt, Scott L ^a   Crowley, Moira ^b   Grow, Jennifer L ^c   Jasin, Lisa R ^d   Klebanoff, Mark A ^e   McClead, Richard E ^e   Meinzen Derr, Jareen ^a   Mohan, Vedagiri K ^f   Stein, Howard ^f   Walsh, Michele C ^b  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

^c AKRON CHILDREN'S HOSPITAL   (United States)

^d Dayton Children's Hospital   (United States)

^e NATIONWIDE CHILDREN S HOSPITAL   (United States)

^f Toledo Children's Hospital   (United States)

Author keywords

Drug withdrawal; Methadone; Morphine; Neonatal abstinence syndrome; Opioid; Treatment protocol

Indexed keywords

METHADONE; MORPHINE;

ARTICLE; CHILD HOSPITALIZATION; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG RESPONSE; FEMALE; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MANAGED CARE; MULTICENTER STUDY; NEWBORN; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROTOCOL COMPLIANCE; TREATMENT DURATION; TREATMENT OUTCOME; WITHDRAWAL SYNDROME;

DRUG WITHDRAWAL; METHADONE; MORPHINE; NEONATAL ABSTINENCE SYNDROME; OPIOID; TREATMENT PROTOCOL;

ADULT; CLINICAL PROTOCOLS; FEMALE; HUMANS; HYPNOTICS AND SEDATIVES; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; INTENTION TO TREAT ANALYSIS; LENGTH OF STAY; MALE; METHADONE; MORPHINE; NARCOTICS; NEONATAL ABSTINENCE SYNDROME; OPIATE SUBSTITUTION TREATMENT; PHENOBARBITAL; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84905251182     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2013-4036     Document Type: Article

References (26)

1. Behnke M, Smith VC; Committee on Substance Abuse; Committee on Fetus and Newborn. Prenatal substance abuse: short- and long-term effects on the exposed fetus. Pediatrics. 2013;131(3). Available at: www.pediatrics.org/cgi/content/ full/131/3/e1009
2. Patrick SW, Schumacher RE, Benneyworth BD, Krans EE, McAllister JM, Davis MM. Neonatal abstinence syndrome and associated health care expenditures: United States, 2000-2009. JAMA. 2012;307(18):1934-1940
3. American Academy of Pediatrics Committee on Drugs. Neonatal drug withdrawal. Pediatrics. 1998;101(6):1079-1088
4. Kandall SR, Gartner LM. Late presentation of drug withdrawal symptoms in newborns. Am J Dis Child. 1974;127(1):58-61
5. Kaltenbach K, Berghella V, Finnegan L. Opioid dependence during pregnancy. Effects and management. Obstet Gynecol Clin North Am. 1998;25(1):139-151 (Pubitemid 28141705)
6. Dashe JS, Sheffield JS, Olscher DA, Todd SJ, Jackson GL, Wendel GD. Relationship between maternal methadone dosage and neonatal withdrawal. Obstet Gynecol. 2002;100(6):1244-1249 (Pubitemid 35449191)
7. Rosen TS, Pippenger CE. Pharmacologic observations on the neonatal withdrawal syndrome. J Pediatr. 1976;88(6):1044-1048
8. Choo RE, Huestis MA, Schroeder JR, Shin AS, Jones HE. Neonatal abstinence syndrome in methadone-exposed infants is altered by level of prenatal tobacco exposure. Drug Alcohol Depend. 2004;75(3):253-260 (Pubitemid 38993295)
9. Abdel-Latif ME, Pinner J, Clews S, Cooke F, Lui K, Oei J. Effects of breast milk on the severity and outcome of neonatal abstinence syndrome among infants of drug-dependent mothers. Pediatrics. 2006;117(6). Available at: www.pediatrics.org/cgi/content/full/117/6/e1163
10. Isemann B, Meinzen-Derr J, Akinbi H. Maternal and neonatal factors impacting response to methadone therapy in infants treated for neonatal abstinence syndrome. J Perinatol. 2011;31(1):25-29
11. Johnson K, Greenough A, Gerada C. Maternal drug use and length of neonatal unit stay. Addiction. 2003;98(6):785-789 (Pubitemid 36688063)
12. Lainwala S, Brown ER, Weinschenk NP, Blackwell MT, Hagadorn JI. A retrospective study of length of hospital stay in infants treated for neonatal abstinence syndrome with methadone versus oral morphine preparations. Adv Neonatal Care. 2005;5(5):265-272 (Pubitemid 41825766)
13. Kenan K, Mack K, Paulozzi L. Trends in prescriptions for oxycodone and other commonly used opioids in the United States, 2000-2010. Open Med. 2012;6(2):e41-e47
14. Bateman BT, Hernandez-Diaz S, Rathmell JP, et al. Patterns of opioid utilization in pregnancy in a large cohort of commercial insurance beneficiaries in the United States. Anesthesiology. 2014;120(5):1216-1224
15. Sarkar S, Donn SM. Management of neonatal abstinence syndrome in neonatal intensive care units: a national survey. J Perinatol. 2006;26(1):15-17 (Pubitemid 43135249)
16. Hudak ML, Tan RC; Committee on Drugs; Committee on Fetus and Newborn; American Academy of Pediatrics. Neonatal drug withdrawal. Pediatrics. 2012;129(2). Available at: www.pediatrics.org/cgi/content/full/129/2/e540
17. Jackson L, Ting A, McKay S, Galea P, Skeoch C. A randomised controlled trial of morphine versus phenobarbitone for neonatal abstinence syndrome. Arch Dis Child Fetal Neonatal Ed. 2004;89(4):F300-F304 (Pubitemid 38869667)
18. Lucas K, Knobel RB. Implementing practice guidelines and education to improve care of infants with neonatal abstinence syndrome. Adv Neonatal Care. 2012;12(1):40-45
19. Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap): a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377-381
20. Bigham MT, Amato R, Bondurrant P, et al Ventilator-associated pneumonia in the pediatric intensive care unit: characterizing the problem and implementing a sustainable solution. J Pediatr. 2009;154(4):582-587, e582
21. Horbar JD, Rogowski J, Plsek PE, et al NIC/Q Project Investigators of the Vermont Oxford Network. Collaborative quality improvement for neonatal intensive care. Pediatrics. 2001;107(1):14-22 (Pubitemid 32055409)
22. Product information: phenobarbital oral solution 20mg/5ml. Buffalo Grove, IL: Pack Pharmaceuticals, LLC; 2011
23. Osborn DA, Jeffery HE, Cole MJ. Opiate treatment for opiate withdrawal in newborn infants. Cochrane Database Syst Rev. 2010; (10):CD002059
24. Cleary BJ, Donnelly J, Strawbridge J, et al. Methadone dose and neonatal abstinence syndrome-systematic review and meta-analysis. Addiction. 2010;105(12):2071-2084
25. Finnegan LP, Connaughton JF Jr, Kron RE, Emich JP. Neonatal abstinence syndrome: assessment and management. Addict Dis. 1975;2(1-2):141-158
26. Massatti R, Falb M, Yors A, Potts L, Beeghly C, Starr S. Neonatal Abstinence Syndrome and Drug Use Among Pregnant Women in Ohio, 2004-2011. Columbus, OH: Ohio Department of Mental Health and Addiction Services; 2013